As of 31 Dec 2025, 8 institutional investors reported holding 1,068,414 shares of TriSalus Life Sciences, Inc. - *W EXP 08/10/202 (TLSIW).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 1,068,414 | $1,767,549 | +$1,414,646 | $1.66 | 8 |
| 2025 Q3 | 213,878 | $337,374 | +$136,251 | $1.60 | 4 |
| 2025 Q2 | 953,567 | $1,249,227 | +$17,081 | $1.30 | 5 |
| 2025 Q1 | 942,156 | $1,114,172 | -$35,844 | $1.16 | 6 |
| 2024 Q4 | 974,267 | $1,084,417 | +$862,956 | $1.10 | 8 |
| 2024 Q3 | 191,756 | $207,983 | -$3,371,451 | $1.02 | 8 |
| 2024 Q2 | 2,160,468 | $3,708,190 | -$1,141,230 | $1.66 | 19 |
| 2024 Q1 | 3,251,387 | $3,332,596 | -$25,382 | $1.00 | 22 |
| 2023 Q4 | 3,225,216 | $3,724,046 | +$163,809 | $1.19 | 22 |
| 2023 Q3 | 3,181,553 | $1,202,469 | +$1,202,469 | $0.38 | 19 |
| 2023 Q2 | $10.48 | 0 |